Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on May 1, 2008, to report its financial and operating results for the first quarter ended March 31, 2008. The filing itself is a cover document, with the detailed financial and operational information contained within a press release furnished as Exhibit 99.1. Investors should refer to this press release for specific details regarding revenue, expenses, net income, earnings per share, and key operational developments during the quarter.
Key Highlights
- 1REGN announced its Q1 2008 financial and operating results via press release.
- 2The press release is attached as Exhibit 99.1 to the 8-K filing.
- 3The event date for the press release announcement was May 1, 2008.
- 4The reporting period covered is the quarter ended March 31, 2008.
- 5This 8-K serves as notification of the release of the company's quarterly performance data.
- 6Investors need to consult the furnished press release (Exhibit 99.1) for the actual financial figures and operational updates.